# DICLOFENAC POTASSIUM
> **ANDA218011** · Abbreviated New Drug Application (Generic) · Sponsor: TARO · Approved 2024-06-14
## Drug
- **FDA Application Number:** ANDA218011
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DICLOFENAC POTASSIUM
- **Generic name:** DICLOFENAC POTASSIUM
- **Active ingredients:** DICLOFENAC POTASSIUM
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TARO
- **Manufacturer:** Taro Pharmaceuticals U.S.A., Inc.
- **First approval:** 2024-06-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218011)
---
*MORVS · CC0 1.0*